Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M Ya Khavunka"'
Autor:
O P Patrusheva, Yu. V. Trinitatskii, F. A. Khabirov, A. N. Boiko, L P Bosenko, V. V. Vasilovskii, T I Negrich, E V Lekomtseva, Kotov Sv, E V Parshina, M A Sherman, K B Tursunova, L I Volkova, A V Zinkina-Orikhan, M Ya Khavunka, L V Chichanovskaya, P. V. Timchenko, Yu N Lin'kova, S. V. Prokopenko, M. N. Zakharova, D V Sazonov
Publikováno v:
Neuroscience and Behavioral Physiology. 48:883-889
Objectives. To demonstrate equivalence of the efficacies of the drugs Teberif (BCD-033, interferon β-1a) and Rebif (interferon β-1a) in patients with remitting multiple sclerosis (RMS). Materials and methods. A multicenter, double-blind, placebo-co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d72507f3b570c03d3198a0c9343f0a1
https://doi.org/10.1007/s11055-018-0643-z
https://doi.org/10.1007/s11055-018-0643-z
Autor:
D V Sazonov, L I Volkova, O P Patrusheva, L V Chichanovskaya, A V Zinkina-Orikhan, Kotov Sv, M A Sherman, M N Zakharova, T I Negrich, F. A. Khabirov, Yu V Trinitatskiy, L P Bosenko, A N Boyko, P. V. Timchenko, K B Tursunova, E V Parshina, M Ya Khavunka, Yu N Lin'kova, E V Lekomtseva, S. V. Prokopenko, V V Vasilovskiy
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 117(2. Vyp. 2)
To prove the equivalent efficacy of teberif (BCD-033, interferon beta-1) and rebif (interferon beta-1a) in patients with remitting multiple sclerosis (RMS).A multicenter double blind placebo-controlled comparative randomized III phase study included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e93d0210c2394ef5581b6be0957c7270
https://pubmed.ncbi.nlm.nih.gov/28617368
https://pubmed.ncbi.nlm.nih.gov/28617368
Autor:
F. A. Khabirov, M Ya Khavunka, T I Negrich, E V Lekomtseva, Yu V Trinitatskiy, L I Volkova, S. V. Prokopenko, V V Vasilovskiy, E Yu Stukalina, D V Sazonov, O P Patrusheva, Kotov Sv, M A Sherman, A V Zinkina-Orikhan, L V Timchenko, E V Parshina, L P Bosenko, A N Boyko, L V Chichanovskaya, Yu N Lin'kova, M N Zakharova, I G Obukhova, Roman Ivanov
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 119:73
To evaluate efficacy, safety, and tolerability of the treatment with teberif/interferon β-1a, to analyze safety, tolerability and dynamics of key efficacy variables after switching from referent drug rebif to biosimilar teberif in patients with remi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46019bc35b7ad16dd208a674713fb402
https://doi.org/10.17116/jnevro20191192273
https://doi.org/10.17116/jnevro20191192273